EFFECT OF PROTEASE INHIBITOR RO 31-8959 ON EARLY STAGES OF HIV REPLICATION INVITRO

被引：0
|
作者：
PANTHER, LA [1 ]
COOMBS, RW [1 ]
GRETCH, D [1 ]
DELAROSA, C [1 ]
机构：
[1] UNIV WASHINGTON,SEATTLE,WA 98195
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1993年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [1] HIV PROTEINASE-INHIBITOR RO 31-8959 - SELECTIVITY, RESISTANCE AND CLINICAL STATUS
    ROBERTS, NA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 130 - 130
  • [2] ANTIVIRAL PROPERTIES OF THE HIV-1 PROTEINASE-INHIBITOR RO 31-8959
    GALPIN, S
    ROBERTS, NA
    OCONNOR, T
    JEFFRIES, DJ
    KINCHINGTON, D
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1994, 5 (01): : 43 - 45
  • [3] ANTIVIRAL PROPERTIES OF RO 31-8959, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PROTEINASE
    CRAIG, JC
    DUNCAN, IB
    HOCKLEY, D
    GRIEF, C
    ROBERTS, NA
    MILLS, JS
    ANTIVIRAL RESEARCH, 1991, 16 (04) : 295 - 305
  • [4] IN-VITRO RESISTANCE TO AN INHIBITOR OF HIV PROTEINASE (RO 31-8959) RELATIVE TO INHIBITORS OF REVERSE-TRANSCRIPTASE (AZT AND TIBO)
    CRAIG, JC
    WHITTAKER, L
    DUNCAN, IB
    ROBERTS, NA
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 (06): : 335 - 339
  • [5] RESISTANCE OF HIV TYPE-1 TO PROTEINASE-INHIBITOR RO-31-8959
    EBERLE, J
    BECHOWSKY, B
    ROSE, D
    HAUSER, U
    VONDERHELM, K
    GURTLER, L
    NITSCHKO, H
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (06) : 671 - 676
  • [6] Lack of immunotoxicity of saquinavir (Ro 31-8959) used alone or in double or triple combination with AZT and ddC
    Viora, M
    Di Genova, G
    Quaranta, MG
    Boirivant, M
    Camponeschi, B
    JOURNAL OF CLINICAL IMMUNOLOGY, 1998, 18 (05) : 346 - 354
  • [7] Lack of Immunotoxicity of Saquinavir (Ro 31-8959) Used Alone or in Double or Triple Combination with AZT and ddC
    Marina Viora
    Gianfranco Di Genova
    Maria Giovanna Quaranta
    Monica Boirivant
    Barbara Camponeschi
    Journal of Clinical Immunology, 1998, 18 : 346 - 354
  • [8] IN-VITRO SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANT TO RO 31-8959 PROTEINASE-INHIBITOR
    DIANZANI, F
    ANTONELLI, G
    TURRIZIANI, O
    RIVA, E
    DONG, G
    BELLAROSA, D
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 (06): : 329 - 333
  • [9] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1 (HIV-1) INHIBITORY INTERACTIONS BETWEEN PROTEASE INHIBITOR RO 31-8959 AND ZIDOVUDINE, 2',3'-DIDEOXYCYTIDINE, OR RECOMBINANT INTERFERON-ALPHA-A AGAINST ZIDOVUDINE-SENSITIVE OR ZIDOVUDINE-RESISTANT HIV-1 INVITRO
    JOHNSON, VA
    MERRILL, DP
    CHOU, TC
    HIRSCH, MS
    JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (05): : 1143 - 1146
  • [10] MOLECULAR CHARACTERIZATION OF HIV-VARIANTS WITH REDUCED SENSITIVITY TO RO-31-8959, A VIRAL PROTEINASE-INHIBITOR
    JACOBSEN, H
    CRAIG, CJ
    DUNCAN, IB
    HANGGI, M
    YASARGIL, K
    MOUS, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S24 - S24
12345